Yajun Gui

457 total citations · 1 hit paper
21 papers, 281 citations indexed

About

Yajun Gui is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yajun Gui has authored 21 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Biochemistry and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yajun Gui's work include Eicosanoids and Hypertension Pharmacology (6 papers), Hormonal Regulation and Hypertension (6 papers) and Lipoproteins and Cardiovascular Health (3 papers). Yajun Gui is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (6 papers), Hormonal Regulation and Hypertension (6 papers) and Lipoproteins and Cardiovascular Health (3 papers). Yajun Gui collaborates with scholars based in China and United States. Yajun Gui's co-authors include Danyan Xu, Yuan Guo, Jingyuan Chen, Xiangying Deng, Lin Zhao, Tao Yang, Danyan Xu, Qiong Liu, Jiahui Hu and Shilan Zhang and has published in prestigious journals such as Scientific Reports, Experimental Cell Research and Molecular Cancer.

In The Last Decade

Yajun Gui

20 papers receiving 279 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The micro(nano)plastics perspective: exploring cancer development and therapy

2025 25 citations Xiangying Deng, Yajun Gui et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yajun Gui China	10	110	66	63	40	36	21	281
Shuo Sun China	14	100 0.9×	38 0.6×	134 2.1×	37 0.9×	58 1.6×	36	385
Jelena Radovanović Serbia	10	119 1.1×	71 1.1×	57 0.9×	26 0.7×	59 1.6×	22	397
Isabel Amador‐Martínez Mexico	10	132 1.2×	24 0.4×	29 0.5×	23 0.6×	52 1.4×	16	291
Karl Aramouni Lebanon	3	95 0.9×	55 0.8×	43 0.7×	25 0.6×	32 0.9×	4	296
Ana María Gámez-Méndez Mexico	9	117 1.1×	52 0.8×	49 0.8×	29 0.7×	21 0.6×	11	333
Rebecca Hutcheson United States	10	104 0.9×	65 1.0×	76 1.2×	66 1.6×	92 2.6×	13	379
Arun P. Palanisamy United States	11	141 1.3×	64 1.0×	38 0.6×	16 0.4×	28 0.8×	24	430
Linda Turnu Italy	7	91 0.8×	38 0.6×	63 1.0×	20 0.5×	19 0.5×	12	300
Tamara Gojković Serbia	11	74 0.7×	41 0.6×	42 0.7×	67 1.7×	80 2.2×	39	378

Countries citing papers authored by Yajun Gui

Since Specialization

Citations

This map shows the geographic impact of Yajun Gui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yajun Gui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yajun Gui more than expected).

Fields of papers citing papers by Yajun Gui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yajun Gui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yajun Gui. The network helps show where Yajun Gui may publish in the future.

Co-authorship network of co-authors of Yajun Gui

This figure shows the co-authorship network connecting the top 25 collaborators of Yajun Gui. A scholar is included among the top collaborators of Yajun Gui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yajun Gui. Yajun Gui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deng, Xiangying, Yajun Gui, & Lin Zhao. (2025). The micro(nano)plastics perspective: exploring cancer development and therapy. Molecular Cancer. 24(1). 30–30. 25 indexed citations breakdown →

Zhao, Lin, Yajun Gui, Jing Cai, & Xiangying Deng. (2025). Biometallic ions and derivatives: a new direction for cancer immunotherapy. Molecular Cancer. 24(1). 17–17. 13 indexed citations

Zhao, Lin, et al.. (2025). Focus on mechano-immunology: new direction in cancer treatment. International Journal of Surgery. 111(3). 2590–2602. 2 indexed citations

Ouyang, Min, Yajun Gui, Namei Li, & Lin Zhao. (2024). Prognostic model based on tumor stemness genes for triple-negative breast cancer. Scientific Reports. 14(1). 30855–30855.

Gui, Yajun, Xiangying Deng, Namei Li, & Lin Zhao. (2024). PRELP reduce cell stiffness and adhesion to promote the growth and metastasis of colorectal cancer cells by binding to integrin α5. Experimental Cell Research. 441(1). 114151–114151. 6 indexed citations

Hu, Jiahui, et al.. (2024). Aerobic exercise alleviates statin-induced PCSK9 upregulation by increasing epoxyeicosatrienoic acid levels through the FoxO3a–Sirt6 axis. Journal of sport and health science. 14. 101007–101007. 2 indexed citations

Hu, Jiahui, Lei Hao, Hua‐Li Qin, et al.. (2023). Regulatory T Cells in Pathological Cardiac Hypertrophy: Mechanisms and Therapeutic Potential. Cardiovascular Drugs and Therapy. 38(5). 999–1015. 6 indexed citations

Deng, Xiangying, et al.. (2023). Arvanil induces ferroptosis of hepatocellular carcinoma by binding to MICU1. Cancer Gene Therapy. 31(1). 148–157. 6 indexed citations

Xiang, Qunyan, Feng Tian, Jin Xu, et al.. (2022). Postprandial triglyceride-rich lipoproteins promote the adipogenic differentiation of adipose-derived mesenchymal stem cells via the LRP1/caveolin-1/AKT1 pathway. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1868(1). 159236–159236. 3 indexed citations

10.

Gui, Yajun, Jingyuan Chen, Jiahui Hu, et al.. (2020). Efficacy and Safety of Inorganic Nitrate Versus Placebo Treatment in Heart Failure with Preserved Ejection Fraction. Cardiovascular Drugs and Therapy. 34(4). 503–513. 6 indexed citations

11.

Gui, Yajun, Jingyuan Chen, Jiahui Hu, et al.. (2020). Soluble epoxide hydrolase inhibitors improve angiogenic function of endothelial progenitor cells via ERK/p38-mediated miR-126 upregulation in myocardial infarction mice after exercise. Experimental Cell Research. 397(2). 112360–112360. 12 indexed citations

12.

Xiang, Qunyan, Feng Tian, Qiuzhen Lin, et al.. (2019). Comparison of remnant cholesterol levels estimated by calculated and measured LDL-C levels in Chinese patients with coronary heart disease. Clinica Chimica Acta. 500. 75–80. 23 indexed citations

13.

Chen, Jingyuan, Yuan Guo, Yajun Gui, & Danyan Xu. (2018). Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases. Lipids in Health and Disease. 17(1). 17–17. 66 indexed citations

14.

Gui, Yajun, Da Li, Jingyuan Chen, et al.. (2018). Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction. Lipids in Health and Disease. 17(1). 129–129. 13 indexed citations

15.

Liu, Qiong, Xuan Zhao, Ran Peng, et al.. (2017). Soluble epoxide hydrolase inhibitors might prevent ischemic arrhythmias via microRNA-1 repression in primary neonatal mouse ventricular myocytes. Molecular BioSystems. 13(3). 556–564. 11 indexed citations

16.

Gui, Yajun, Tao Yang, Qiong Liu, et al.. (2017). Soluble epoxide hydrolase inhibitors, t-AUCB, regulated microRNA-1 and its target genes in myocardial infarction mice. Oncotarget. 8(55). 94635–94649. 16 indexed citations

17.

Gui, Yajun, Qiong Liu, Yuan Guo, et al.. (2017). Efficacy and safety of statins and exercise combination therapy compared to statin monotherapy in patients with dyslipidaemia: A systematic review and meta-analysis. European Journal of Preventive Cardiology. 24(9). 907–916. 33 indexed citations

18.

Gui, Yajun, et al.. (2016). RKIP corrects impaired beta (2)-adrenergic receptor vasodilatation in hypertension by downregulation of GRK2. International Journal of Cardiology. 207. 359–360. 3 indexed citations

19.

Liu, Qiong, et al.. (2016). Is sEHi lowering LDL-C by reducing expression of PCSK9 through SREBP2 pathway?. International Journal of Cardiology. 207. 361–362. 1 indexed citations

20.

Gui, Yajun, et al.. (2015). The regulatory function of microRNA-1 in arrhythmias. Molecular BioSystems. 12(2). 328–333. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact